Drugs / BIIB144
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07662148 | Jul 2026 → Jun 2028 expected | — | Biogen | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIB144 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07662148 ↗ |
| Route | Intravenous | “Administered IV” NCT07662148 ↗ |